Get the Stockscreener App
1.50
16.28%
0.21
After Hours:
1.50
Estrella Immunopharma Inc stock is traded at $1.50, with a volume of 313.16K.
It is up +16.28% in the last 24 hours and up +42.86% over the past month.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
See More
Previous Close:
$1.29
Open:
$1.33
24h Volume:
313.16K
Relative Volume:
5.15
Market Cap:
$55.60M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-5.00
EPS:
-0.3
Net Cash Flow:
$-18.01M
1W Performance:
+7.14%
1M Performance:
+42.86%
6M Performance:
+72.61%
1Y Performance:
+79.00%
1-Day Range:
$1.3187
$1.50
1-Week Range:
$1.20
$1.50
52-Week Range:
$0.63
$1.78
Estrella Immunopharma Inc Stock (ESLA) Company Profile
Name
Estrella Immunopharma Inc
Sector
Industry
Phone
(510) 318-9098
Address
5858 HORTON STREET, SUITE 370, EMERYVILLE
Compare ESLA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
1.50 | 47.81M | 0 | -8.82M | -18.01M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Estrella Immunopharma Inc Stock (ESLA) Latest News
Is Estrella Immunopharma Inc. stock attractive for income investorsWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
What indicators show strength in Estrella Immunopharma Inc.2025 Price Targets & High Return Stock Watch Alerts - newser.com
How sentiment analysis helps forecast Estrella Immunopharma Inc.Weekly Investment Report & Stock Portfolio Risk Management - newser.com
Leading vs lagging indicators on Estrella Immunopharma Inc. performanceWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Using AI based signals to follow Estrella Immunopharma Inc.July 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
Published on: 2025-10-13 08:06:06 - newser.com
Chart based exit strategy for Estrella Immunopharma Inc.July 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - newser.com
What candlestick patterns are forming on Estrella Immunopharma Inc.July 2025 Final Week & AI Driven Stock Movement Reports - newser.com
How to manage a losing position in Estrella Immunopharma Inc.July 2025 Reactions & Accurate Buy Signal Alerts - newser.com
Can Estrella Immunopharma Inc. recover in the next quarterRisk Management & Real-Time Volume Analysis Alerts - newser.com
Applying chart zones and confluence areas to Estrella Immunopharma Inc.July 2025 PostEarnings & Pattern Based Trade Signal System - newser.com
Estrella Immunopharma regains Nasdaq compliance after capital raise By Investing.com - Investing.com Nigeria
How to use Fibonacci retracement on Estrella Immunopharma Inc.Market Risk Report & Fast Moving Stock Watchlists - newser.com
Estrella Immunopharma regains Nasdaq compliance after capital raise - Investing.com
Estrella Immunopharma Inc. stock chart pattern explained2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
Estrella Immunopharma regains compliance with Nasdaq listing requirements - MarketScreener
Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements - Business Wire
Real time alert setup for Estrella Immunopharma Inc. performanceJuly 2025 Breakouts & Safe Entry Point Identification - newser.com
Why Estrella Immunopharma Inc. stock attracts high net worth investorsJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Published on: 2025-10-05 04:47:47 - newser.com
Will Estrella Immunopharma Inc. stock recover after recent dropIPO Watch & Free Growth Oriented Trading Recommendations - newser.com
Order flow analysis tools used on Estrella Immunopharma Inc.July 2025 Reactions & Consistent Profit Trade Alerts - newser.com
Published on: 2025-10-05 02:31:05 - newser.com
Is Estrella Immunopharma Inc a good long term investmentDividend Aristocrats List & Free Explosive Wealth Accumulation - earlytimes.in
Published on: 2025-10-03 04:11:09 - newser.com
Morning Market Movers: ASBP, FICO, ESLA See Big Swings - RTTNews
Estrella Immunopharma Regains Nasdaq Compliance - TipRanks
Estrella Immunopharma regains Nasdaq compliance on bid price and market value - Investing.com
What drives Estrella Immunopharma Inc stock priceEmerging Market Stocks & Fast Profit Trading Ideas - earlytimes.in
Published on: 2025-09-29 09:59:51 - newser.com
Estrella Immunopharma Inc Stock (ESLA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):